Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters.

Hao, Ke; Luk, John M; Lee, Nikki P Y; Mao, Mao; Zhang, Chunsheng; Ferguson, Mark D; Lamb, John; Dai, Hongyue; Ng, Irene O; Sham, Pak C; Poon, Ronnie T P

Hao, Ke; Luk, John M; Lee, Nikki P Y; Mao, Mao; Zhang, Chunsheng; Ferguson, Mark D; Lamb, John; Dai, Hongyue; Ng, Irene O; Sham, Pak C; Poon, Ronnie T P.

Affiliation

Hao K; 1Rosetta Inpharmatics LLC, Merck Research Laboratories, Seattle, WA, USA. ke_hao@merck.com

BMC Cancer ; 9: 389, 2009 Nov 03.

Article in En | MEDLINE | ID: mdl-19886989

Subject(s)

Carcinoma, Hepatocellular/mortality; Carcinoma, Hepatocellular/surgery; Liver Neoplasms/mortality; Liver Neoplasms/surgery; Area Under Curve; Carcinoma, Hepatocellular/pathology; Disease-Free Survival; Humans; Kaplan-Meier Estimate; Liver Neoplasms/pathology; Neoplasm Staging; Prognosis; ROC Curve; Retrospective Studies; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2009 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google